These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 20160347)

  • 1. Organotypic specificity of key RET adaptor-docking sites in the pathogenesis of neurocristopathies and renal malformations in mice.
    Jain S; Knoten A; Hoshi M; Wang H; Vohra B; Heuckeroth RO; Milbrandt J
    J Clin Invest; 2010 Mar; 120(3):778-90. PubMed ID: 20160347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Critical and distinct roles for key RET tyrosine docking sites in renal development.
    Jain S; Encinas M; Johnson EM; Milbrandt J
    Genes Dev; 2006 Feb; 20(3):321-33. PubMed ID: 16452504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinct turnover of alternatively spliced isoforms of the RET kinase receptor mediated by differential recruitment of the Cbl ubiquitin ligase.
    Scott RP; Eketjäll S; Aineskog H; Ibáñez CF
    J Biol Chem; 2005 Apr; 280(14):13442-9. PubMed ID: 15677445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two distinct mutations of the RET receptor causing Hirschsprung's disease impair the binding of signalling effectors to a multifunctional docking site.
    Geneste O; Bidaud C; De Vita G; Hofstra RM; Tartare-Deckert S; Buys CH; Lenoir GM; Santoro M; Billaud M
    Hum Mol Genet; 1999 Oct; 8(11):1989-99. PubMed ID: 10484767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Grb2 binding to the different isoforms of Ret tyrosine kinase.
    Alberti L; Borrello MG; Ghizzoni S; Torriti F; Rizzetti MG; Pierotti MA
    Oncogene; 1998 Sep; 17(9):1079-87. PubMed ID: 9764818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deciphering adaptor specificity in GFL-dependent RET-mediated proliferation and neurite outgrowth.
    Gustin JA; Yang M; Johnson EM; Milbrandt J
    J Neurochem; 2007 Aug; 102(4):1184-94. PubMed ID: 17663753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Various mechanisms cause RET-mediated signaling defects in Hirschsprung's disease.
    Pelet A; Geneste O; Edery P; Pasini A; Chappuis S; Atti T; Munnich A; Lenoir G; Lyonnet S; Billaud M
    J Clin Invest; 1998 Mar; 101(6):1415-23. PubMed ID: 9502784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Signaling adaptor ShcD suppresses extracellular signal-regulated kinase (Erk) phosphorylation distal to the Ret and Trk neurotrophic receptors.
    Wills MK; Keyvani Chahi A; Lau HR; Tilak M; Guild BD; New LA; Lu P; Jacquet K; Meakin SO; Bisson N; Jones N
    J Biol Chem; 2017 Apr; 292(14):5748-5759. PubMed ID: 28213521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phosphotyrosine 1062 is critical for the in vivo activity of the Ret9 receptor tyrosine kinase isoform.
    Wong A; Bogni S; Kotka P; de Graaff E; D'Agati V; Costantini F; Pachnis V
    Mol Cell Biol; 2005 Nov; 25(21):9661-73. PubMed ID: 16227613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD2-associated protein (CD2AP) enhances casitas B lineage lymphoma-3/c (Cbl-3/c)-mediated Ret isoform-specific ubiquitination and degradation via its amino-terminal Src homology 3 domains.
    Calco GN; Stephens OR; Donahue LM; Tsui CC; Pierchala BA
    J Biol Chem; 2014 Mar; 289(11):7307-19. PubMed ID: 24425877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential recruitment of E3 ubiquitin ligase complexes regulates RET isoform internalization.
    Hyndman BD; Crupi MJF; Peng S; Bone LN; Rekab AN; Lian EY; Wagner SM; Antonescu CN; Mulligan LM
    J Cell Sci; 2017 Oct; 130(19):3282-3296. PubMed ID: 28794017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Signaling complexes and protein-protein interactions involved in the activation of the Ras and phosphatidylinositol 3-kinase pathways by the c-Ret receptor tyrosine kinase.
    Besset V; Scott RP; Ibáñez CF
    J Biol Chem; 2000 Dec; 275(50):39159-66. PubMed ID: 10995764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ret oncogene signal transduction via a IRS-2/PI 3-kinase/PKB and a SHC/Grb-2 dependent pathway: possible implication for transforming activity in NIH3T3 cells.
    Hennige AM; Lammers R; Arlt D; Höppner W; Strack V; Niederfellner G; Seif FJ; Häring HU; Kellerer M
    Mol Cell Endocrinol; 2000 Sep; 167(1-2):69-76. PubMed ID: 11000521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glial cell line-derived neurotrophic factor differentially stimulates ret mutants associated with the multiple endocrine neoplasia type 2 syndromes and Hirschsprung's disease.
    Carlomagno F; Melillo RM; Visconti R; Salvatore G; De Vita G; Lupoli G; Yu Y; Jing S; Vecchio G; Fusco A; Santoro M
    Endocrinology; 1998 Aug; 139(8):3613-9. PubMed ID: 9681515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Docking protein FRS2 links the protein tyrosine kinase RET and its oncogenic forms with the mitogen-activated protein kinase signaling cascade.
    Melillo RM; Santoro M; Ong SH; Billaud M; Fusco A; Hadari YR; Schlessinger J; Lax I
    Mol Cell Biol; 2001 Jul; 21(13):4177-87. PubMed ID: 11390647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Single RET Mutation in Hirschsprung Disease Induces Intestinal Aganglionosis Via a Dominant-Negative Mechanism.
    Sunardi M; Ito K; Sato Y; Uesaka T; Iwasaki M; Enomoto H
    Cell Mol Gastroenterol Hepatol; 2023; 15(6):1505-1524. PubMed ID: 36521661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss-of-function mutation of c-Ret causes cerebellar hypoplasia in mice with Hirschsprung disease and Down's syndrome.
    Ohgami N; Iizuka A; Hirai H; Yajima I; Iida M; Shimada A; Tsuzuki T; Jijiwa M; Asai N; Takahashi M; Kato M
    J Biol Chem; 2021; 296():100389. PubMed ID: 33561442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correction of Hirschsprung-Associated Mutations in Human Induced Pluripotent Stem Cells Via Clustered Regularly Interspaced Short Palindromic Repeats/Cas9, Restores Neural Crest Cell Function.
    Lai FP; Lau ST; Wong JK; Gui H; Wang RX; Zhou T; Lai WH; Tse HF; Tam PK; Garcia-Barcelo MM; Ngan ES
    Gastroenterology; 2017 Jul; 153(1):139-153.e8. PubMed ID: 28342760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of intracellular signals via tyrosine 1062 in RET activated by glial cell line-derived neurotrophic factor.
    Hayashi H; Ichihara M; Iwashita T; Murakami H; Shimono Y; Kawai K; Kurokawa K; Murakumo Y; Imai T; Funahashi H; Nakao A; Takahashi M
    Oncogene; 2000 Sep; 19(39):4469-75. PubMed ID: 11002419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Ret(C620R) mutation affects renal and enteric development in a mouse model of Hirschsprung's disease.
    Carniti C; Belluco S; Riccardi E; Cranston AN; Mondellini P; Ponder BA; Scanziani E; Pierotti MA; Bongarzone I
    Am J Pathol; 2006 Apr; 168(4):1262-75. PubMed ID: 16565500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.